These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 29843726)
1. Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP. Peak J; Goranitis I; Day E; Copello A; Freemantle N; Frew E Health Qual Life Outcomes; 2018 May; 16(1):106. PubMed ID: 29843726 [TBL] [Abstract][Full Text] [Related]
2. Measuring Health and Broader Well-Being Benefits in the Context of Opiate Dependence: The Psychometric Performance of the ICECAP-A and the EQ-5D-5L. Goranitis I; Coast J; Day E; Copello A; Freemantle N; Seddon J; Bennett C; Frew E Value Health; 2016; 19(6):820-828. PubMed ID: 27712710 [TBL] [Abstract][Full Text] [Related]
3. Quantifying the Relationship between Capability and Health in Older People: Can't Map, Won't Map. Franklin M; Payne K; Elliott RA Med Decis Making; 2018 Jan; 38(1):79-94. PubMed ID: 29056069 [TBL] [Abstract][Full Text] [Related]
4. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Hawton A; Green C; Telford C; Zajicek J; Wright D Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811 [TBL] [Abstract][Full Text] [Related]
5. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China. Yang Q; Yu XX; Zhang W; Li H Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531 [TBL] [Abstract][Full Text] [Related]
6. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease. Moore A; Young CA; Hughes DA Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280 [TBL] [Abstract][Full Text] [Related]
7. Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia. Meregaglia M; Borsoi L; Cairns J; Tarricone R Eur J Health Econ; 2019 Mar; 20(2):181-193. PubMed ID: 28948436 [TBL] [Abstract][Full Text] [Related]
8. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data. Kim HL; Kim D; Jang EJ; Lee MY; Song HJ; Park SY; Cho SK; Sung YK; Choi CB; Won S; Bang SY; Cha HS; Choe JY; Chung WT; Hong SJ; Jun JB; Kim J; Kim SK; Kim TH; Kim TJ; Koh E; Lee H; Lee HS; Lee J; Lee SS; Lee SW; Park SH; Shim SC; Yoo DH; Yoon BY; Bae SC; Lee EK Rheumatol Int; 2016 Apr; 36(4):505-13. PubMed ID: 26849891 [TBL] [Abstract][Full Text] [Related]
9. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis. Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865 [TBL] [Abstract][Full Text] [Related]
10. Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis. Martín-Fernández J; Morey-Montalvo M; Tomás-García N; Martín-Ramos E; Muñoz-García JC; Polentinos-Castro E; Rodríguez-Martínez G; Arenaza JC; García-Pérez L; Magdalena-Armas L; Bilbao A Health Qual Life Outcomes; 2020 Jun; 18(1):184. PubMed ID: 32539838 [TBL] [Abstract][Full Text] [Related]
11. Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure. Kularatna S; Senanayake S; Chen G; Parsonage W Health Qual Life Outcomes; 2020 Apr; 18(1):115. PubMed ID: 32349782 [TBL] [Abstract][Full Text] [Related]
15. A Validation Study of the EQ-5D-5L and ICEpop Capability Measure for Older People Among Older Individuals With Depressive Symptoms in Brazil. Nakamura CA; Mitchell PM; Peters TJ; Moreno-Agostino D; Araya R; Scazufca M; Hollingworth W Value Health Reg Issues; 2022 Jul; 30():91-99. PubMed ID: 35325703 [TBL] [Abstract][Full Text] [Related]
16. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms. Doble B; Lorgelly P Qual Life Res; 2016 Apr; 25(4):891-911. PubMed ID: 26391884 [TBL] [Abstract][Full Text] [Related]
17. Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients. Shafie AA; Chhabra IK; Wong JHY; Mohammed NS Eur J Health Econ; 2021 Jul; 22(5):735-747. PubMed ID: 33860379 [TBL] [Abstract][Full Text] [Related]
18. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea. Lim J; Choi SE; Bae E; Kang D; Lim EA; Shin GS Health Qual Life Outcomes; 2019 Jun; 17(1):97. PubMed ID: 31170982 [TBL] [Abstract][Full Text] [Related]
19. Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study. Jiang L; Zhou H; Yang Q; Luo X; Huang D Qual Life Res; 2024 Mar; 33(3):805-816. PubMed ID: 38148367 [TBL] [Abstract][Full Text] [Related]
20. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis. Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K; Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]